CompaniesShennon Biotechnologies
Shennon Biotechnologies logo

Shennon Biotechnologies

active
San Francisco, CA, United States
Founded 2021
Website
About

Proprietary single cell platform to create more effective immunotherapies

Areas of Focus

Categories

Stem Cell & Cellular TherapyBiotech
Team (20)
Benjamin Greenbaum, PhD
Benjamin Greenbaum, PhD
Shennon Biotechnologies
team_member
Bianca Pierrat
Bianca Pierrat
Shennon Biotechnologies
team_member
Centered around people
Shennon Biotechnologies
team_member
Dan Griffith, PhD
Dan Griffith, PhD
Shennon Biotechnologies
team_member
David Weitz, PhD
David Weitz, PhD
Shennon Biotechnologies
team_member
Ian Chen, PhD
Ian Chen, PhD
Shennon Biotechnologies
team_member
View all 20 team members →
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

600

By Status

UNKNOWN: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
Today
NCT03167476
NCT03000621
NCT03059524
Hover over trial bars to see details

Recent Trials

NCT03059524Collaborator
Dynamic Monitoring of Circulating microRNA Changes in Patients With or Without Multiple Organ Failure
N/AUnknown
200 participants
Started: Jan 31, 2017 · Completed: Dec 31, 2018
NCT03000621Collaborator
Comparative Study of Circulating microRNA Changes in Patients With Liver Injury and Healthy Subjects
N/AUnknown
200 participants
Started: Dec 31, 2016 · Completed: Dec 31, 2019
NCT03167476Collaborator
Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma
N/AUnknown
200 participants
Started: Aug 1, 2016 · Completed: Dec 1, 2018
Funding History (1)
D
Mar 16, 2023
Filing
Locations (1)
Headquarters
San Francisco, CA, United States
Map

Loading map...